
    
      Phase 4 Double-blind, Randomized, Parallel Group, Placebo-controlled Study of the Efficacy
      And Safety of Methylphenidate Hydrochloride (HCl) Extended Release Chewable Tablets (ERCT) In
      4-5 Year Old Children With Attention Deficit Hyperactivity Disorder (ADHD)
    
  